4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-145821
Chief Financial Officer sold 5,000 shares at an average $17.47 ($87,325)
From the SEC's structured data for this filing
Trades in this filing
MCGRATH JOHN · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-10-11 | Sale : show line 1 in the form | −2,500 | $18.52 | $46,300 | 96,823 | D |
| 2016-10-12 | Sale : show line 2 in the form | −2,500 | $16.41 | $41,025 | 94,323 | D |
| Open-market sales · 5,000 sh · avg $17.47 · $87,325 | ||||||
Loading xslF345X03/doc4.xml…